Institutional members access full text with Ovid®

Share this article on:

Altered Mental Status

Douglas, Vanja C. MD; Josephson, S. Andrew MD

doi: 10.1212/01.CON.0000407055.17661.33
Review Articles

Purpose of Review: Altered mental status is a common reason for neurologic consultation. Although it is often due to a systemic infection or metabolic derangement, a host of other etiologies can lead to irreversible brain injury if they are not promptly identified and treated. A systematic approach to the patient is important, with an understanding of when to initiate a more advanced and potentially more resource-intense diagnostic workup.

Recent Findings: The last decade has seen advances in both the diagnosis and treatment of altered mental status. A significant step forward in the diagnosis of patients with otherwise unexplained encephalitis has been the identification of numerous antibodies associated with paraneoplastic and nonparaneoplastic autoimmune encephalitis. The use of continuous electroencephalography has shown that a significant proportion of otherwise unexplained altered mental status may be caused by nonconvulsive seizures. Several studies have demonstrated that proactive, multicomponent interventions may be effective in preventing hospital-acquired delirium. The recent introduction of dexmedetomidine may lead to decreased rates of delirium in the intensive care unit if the results of clinical trials are borne out in practice.

Summary: This article discusses causes of altered mental status, an initial approach to evaluating the patient, and elements of the advanced diagnostic workup. The article concludes with a general discussion of prevention and treatment.

Address correspondence to Dr Vanja C. Douglas, UCSF Department of Neurology, Box 0114, 505 Parnassus Avenue M798, San Francisco, CA 94143,

Relationship Disclosure: Dr Douglas has served as editor-in-chief of The Neurohospitalist and has received personal compensation for medical record review and expert witness testimony. Dr Josephson has received personal compensation for editorial activities from Annals of Neurology and Journal Watch Neurology.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Douglas discusses the use of antipsychotics for the treatment of agitated delirium. Dr Josephson reports no disclosure.

© 2011 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website